This inventor holds 1 USPTO granted patent. Top assignee: Bioinfobank Sp. Z O. O.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Anna Bujko: Innovator in Cytotoxin Research
Introduction
Anna Bujko is a prominent inventor based in Kalisz, Poland. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant cytotoxins. Her innovative work focuses on enhancing the selective elimination of tumor cells, which has important implications for cancer treatment.
Latest Patents
Anna Bujko holds a patent for a recombinant cytotoxin, which includes a method of producing it. The invention involves modifying proteinaceous toxins through the addition of a nuclear localization signal (NLS) motif. This modification allows the resulting cytotoxin to selectively target and eliminate proliferating cells, especially tumor cells. She has 1 patent to her name.
Career Highlights
Anna is currently associated with Bioinfobank Sp. z o.o., where she continues her research and development efforts. Her work is pivotal in advancing therapeutic strategies for cancer treatment, showcasing her dedication to improving patient outcomes through innovative solutions.
Collaborations
Anna collaborates with notable colleagues, including Magdalena Lukasiak and Jaroslaw Dastych. Their combined expertise enhances the research efforts at Bioinfobank and contributes to the advancement of biotechnology.
Conclusion
Anna Bujko is a trailblazer in the field of cytotoxin research, with her innovative approaches paving the way for future advancements in cancer therapy. Her contributions are vital to the ongoing fight against cancer, and her work continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile